TY - JOUR
T1 - GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells
AU - Kubic, Jennifer D.
AU - Mascarenhas, Joseph B.
AU - Iizuka, Takumi
AU - Wolfgeher, Don
AU - Lang, Deborah
PY - 2012/8
Y1 - 2012/8
N2 - GSK-3 is a serine/threonine kinase involved in a diverse range of cellular processes. GSK-3 exists in two isoforms, GSK-3α and GSK-3β, which possess some functional redundancy but also play distinct roles depending on developmental and cellular context. In this article, we found that GSK-3 actively promoted cell growth and survival in melanoma cells, and blocking this activity with small-molecule inhibitor SB216763 or gene-specific siRNA decreased proliferation, increased apoptosis, and altered cellular morphology. These alterations coincided with loss of PAX3, a transcription factor implicated in proliferation, survival, and migration of developing melanoblasts. We further found that PAX3 directly interacted with and was phosphorylated in vitro on a number of residues by GSK-3β. In melanoma cells, direct inhibition of PAX3 lead to cellular changes that paralleled the response to GSK-3 inhibition. Maintenance of PAX3 expression protected melanoma cells from the anti-tumor effects of SB216763. These data support a model wherein GSK-3 regulates proliferation and morphology of melanoma through phosphorylation and increased levels of PAX3.
AB - GSK-3 is a serine/threonine kinase involved in a diverse range of cellular processes. GSK-3 exists in two isoforms, GSK-3α and GSK-3β, which possess some functional redundancy but also play distinct roles depending on developmental and cellular context. In this article, we found that GSK-3 actively promoted cell growth and survival in melanoma cells, and blocking this activity with small-molecule inhibitor SB216763 or gene-specific siRNA decreased proliferation, increased apoptosis, and altered cellular morphology. These alterations coincided with loss of PAX3, a transcription factor implicated in proliferation, survival, and migration of developing melanoblasts. We further found that PAX3 directly interacted with and was phosphorylated in vitro on a number of residues by GSK-3β. In melanoma cells, direct inhibition of PAX3 lead to cellular changes that paralleled the response to GSK-3 inhibition. Maintenance of PAX3 expression protected melanoma cells from the anti-tumor effects of SB216763. These data support a model wherein GSK-3 regulates proliferation and morphology of melanoma through phosphorylation and increased levels of PAX3.
UR - http://www.scopus.com/inward/record.url?scp=84865294455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865294455&partnerID=8YFLogxK
U2 - 10.1158/1541-7786.MCR-11-0387
DO - 10.1158/1541-7786.MCR-11-0387
M3 - Article
C2 - 22679108
SN - 1541-7786
VL - 10
SP - 1065
EP - 1076
JO - Molecular Cancer Research
JF - Molecular Cancer Research
IS - 8
ER -